We serve 2-hydroxy-6-oxo-4-(trifluoromethyl)-1H-pyridine-3-carbonitrile CAS:3335-46-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Contact us for information like 2-hydroxy-6-oxo-4-(trifluoromethyl)-1H-pyridine-3-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-dihydroxy-4-(trifluoromethyl)pyridine-3-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Cyan-6-hydroxy-4-trifluormethyl-2(1H)-pyridon Use and application,2,6-Dihydroxy-4-(trifluoromethyl)nicotinonitrile technical grade,usp/ep/jp grade.
Related News: Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.Furfuryl Mercaptan manufacturer Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.Ethyl dichlorophosphate supplier The UK Foreign Office advised Britons against all but essential travel to mainland China, and airlines around the world suspended flights or offered full refunds or destination and date changes.1-Butanethiol vendor The UK Foreign Office advised Britons against all but essential travel to mainland China, and airlines around the world suspended flights or offered full refunds or destination and date changes.With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.